Dianthus Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Dianthus Therapeutics has a total shareholder equity of $372.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $382.5M and $9.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$377.04m |
Equity | US$372.69m |
Total liabilities | US$9.78m |
Total assets | US$382.46m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DNTH's short term assets ($380.9M) exceed its short term liabilities ($9.0M).
Long Term Liabilities: DNTH's short term assets ($380.9M) exceed its long term liabilities ($816.0K).
Debt to Equity History and Analysis
Debt Level: DNTH is debt free.
Reducing Debt: DNTH has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DNTH has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: DNTH has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 45% each year